Creador targets mid-market investments in Southeast Asia and India. CEO Brahmal Vasudevan explains why he sees limited competition outside of India, and why he’s excited about the Philippines
Q: Fund I closed in early 2013 and then Fund II closed in late 2014. Now you are in the market with Fund III. Do you get a lot of questions about the pace of fundraising? A: Pace is certainly one of...
India’s Innoven Capital, a joint venture between UOB and Temasek Holdings-owned Seviora Holdings, has fractionalised a USD 50m venture debt fund using blockchain and smart contracts.
OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.
Northleaf Capital Partners, a Canada-based asset manager that invests in private equity, private credit, and infrastructure, has opened a Tokyo office to spearhead fundraising activity in Asia and is considering the addition of a Korea presence.